A Phase I Dose-escalation Study of a Single Administration of Extended-Release Injectable Suspension (ND-340)

Summary

This study focused on ND-340 extended release injection suspension for patients undergoing total knee arthroplasty with a one-time nerve blockade to assess drug side effects, pharmacokinetics and the effect of pain relief after surgery.

Timeline

Start

2020-10-15

Primary completion

2025-12

Completion

2026-06

Outcome

Outcome not reported

Stopped: “pending”

Drugs

Indications